Amid overwhelming public demand for alternative COVID-19 vaccines, IHH Singapore officially began offering its first batch of 10,000 doses of the Sinopharm COVID-19 vaccine on 30 August.
With this first batch of 10,000 doses offered across Gleneagles Hospital, Mount Elizabeth Hospital and Parkway Shenton clinics in Duxton and One Raffles Quay, IHH Singapore is able to inoculate some 5,000 people.
Dr Noel Yeo, Chief Operating Officer of IHH Healthcare Singapore, said that more than 6,000 individuals had registered their interest to receive the Sinopharm vaccine even before it was made available.
"We were aware there is a demand for alternative vaccines. However, the response for Sinopharm has been overwhelming. We are making plans for second orders but we have to clear approvals from HSA (Health Sciences Authority) first,” he said.
For those looking for alternative vaccines, the Sinopharm vaccine has a reported higher efficacy rate compared to the Sinovac vaccine - 79 per cent compared to 51 per cent - and reportedly milder side effects.
Related Stories
Gleneagles Hong Kong and CTF Life Partner to Deliver Seamless, Personalised Healthcare Experiences
IHH Singapore Honours Its Healthcare Humanity Award Recipients 2025
Mount Elizabeth Royal Square: Specialised Day Care, All in a Day
Parkway Radiology Launches MammoXpress to Bring Preventive Care Closer to Women
Mount Elizabeth Hospital Walks the Talk for Health and Community
Championing Mental Health: Care That Empowers, Where It Matters
"Care That Empowers, Where It Matters" is at the heart of IHH Healthcare's Mental Health Week from 11 to 17 October 2025 to foster a supportive workplace.
